Form 4: Beta Bionics CMO Sells Shares for Tax Obligations

Beta Bionics' Chief Medical Officer, Steven Jon Russell, sold 1,015 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Steven Jon Russell, Chief Medical Officer of Beta Bionics, Inc. (BBNX), reported a sale of common stock.
• The transaction involved 1,015 shares of common stock.
• The shares were sold at a weighted average price of $18.8632 per share.
• The sale was executed on September 2, 2025.
• The purpose of the sale was to cover tax withholding obligations arising from the vesting of restricted stock units.
• Following this transaction, Mr. Russell beneficially owns 71,017 shares of Beta Bionics common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine insider sale to cover tax obligations upon RSU vesting, which is a common and expected event, thus having a neutral impact on sentiment.

Positives

• The sale was for tax withholding obligations, indicating the vesting of restricted stock units, which typically aligns executive incentives with shareholder value.

Negatives

• An insider, the Chief Medical Officer, sold 1,015 shares of company stock.

Future Outlook

NA

Management Comments

• The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

Industry Context

NA

Stakeholder Impact

• Shareholders: Minor dilution from the sale, but the underlying RSU vesting can be seen as positive for executive alignment. The sale itself is small relative to total shares outstanding.
• Management: The Chief Medical Officer realized value from vested equity.

Key Dates

Recommendation

The filing details a routine insider sale by the Chief Medical Officer to cover tax obligations associated with restricted stock unit vesting. This is a common and expected event and does not provide new fundamental information to warrant a change in investment recommendation. The transaction is not indicative of a change in management's outlook on the company's prospects.

Keywords

Beta Bionics, BBNX, Steven Jon Russell, Chief Medical Officer, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding